EHG — Econ Healthcare (Asia) Income Statement
0.000.00%
- SG$91.74m
- SG$108.23m
- SG$50.79m
- 81
- 67
- 97
- 96
Annual income statement for Econ Healthcare (Asia), fiscal year end - March 31st, SGD millions except per share, conversion factor applied.
2020 March 31st | C2021 March 31st | 2022 March 31st | R2023 March 31st | 2024 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 21.9 | 37.7 | 38.9 | 43 | 50.8 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 16.1 | 29.5 | 36.6 | 34.9 | 43.2 |
Operating Profit | 5.81 | 8.17 | 2.35 | 8.16 | 7.58 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 4.36 | 6.83 | 0.861 | 7.22 | 6.58 |
Provision for Income Taxes | |||||
Net Income After Taxes | 3.88 | 5.37 | -0.056 | 5.75 | 6.33 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 4.04 | 5.7 | 0.35 | 4.85 | 6.42 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 4.04 | 5.7 | 0.35 | 4.85 | 6.42 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.02 | 0.028 | 0.002 | 0.023 | 0.024 |
Dividends per Share |